PURPOSE: Identification of putative new virulence factors as additional targets for therapeutic approaches alternative to antibiotic treatment of multi-resistant enterococcal infections. METHODS: The EF3314 gene, coding for a putative surface-exposed antigen, was identified by the analysis of the Enterococcus faecalis V583 genome for LPXTG-motif cell wall anchor surface protein genes. A non-polar EF3314 gene deletion mutant in the E. faecalis 12030 human clinical isolate was obtained. The wild type and the isogenic mutant strain were investigated for biofilm formation, adherence to Hela cells, survival in human macrophages and a Caenorhabditis elegans infection model. The aminoterminal portion of the EF3314 protein was overexpressed in E. coli to obtain mouse polyclonal antibodies for use in Western blotting and immunolocalization experiments. RESULTS: The EF3314 gene has an unusually high GC content (46.88% vs. an average of 37.5% in the E. faecalis chromosome) and encodes a protein of 1744 amino acids that presents a series of 14 imperfect repeats of 90 amino acids covering almost the entire length of the protein. Its global organization is similar to the alpha-like protein family of group B streptococci, enterococcal surface protein Esp and biofilm associated protein Bap from S. aureus. The EF3314 gene was always present and specific for E. faecalis strains of human, food and animal origin. Differences in size depended on variable numbers of repeats in the repetitive region. CONCLUSIONS: EF3314 is a newly described, surface exposed protein that contributes to the virulence properties of E. faecalis.
PURPOSE: Identification of putative new virulence factors as additional targets for therapeutic approaches alternative to antibiotic treatment of multi-resistant enterococcal infections. METHODS: The EF3314 gene, coding for a putative surface-exposed antigen, was identified by the analysis of the Enterococcus faecalis V583 genome for LPXTG-motif cell wall anchor surface protein genes. A non-polar EF3314 gene deletion mutant in the E. faecalis 12030human clinical isolate was obtained. The wild type and the isogenic mutant strain were investigated for biofilm formation, adherence to Hela cells, survival in human macrophages and a Caenorhabditis elegans infection model. The aminoterminal portion of the EF3314 protein was overexpressed in E. coli to obtain mouse polyclonal antibodies for use in Western blotting and immunolocalization experiments. RESULTS: The EF3314 gene has an unusually high GC content (46.88% vs. an average of 37.5% in the E. faecalis chromosome) and encodes a protein of 1744 amino acids that presents a series of 14 imperfect repeats of 90 amino acids covering almost the entire length of the protein. Its global organization is similar to the alpha-like protein family of group B streptococci, enterococcal surface protein Esp and biofilm associated protein Bap from S. aureus. The EF3314 gene was always present and specific for E. faecalis strains of human, food and animal origin. Differences in size depended on variable numbers of repeats in the repetitive region. CONCLUSIONS:EF3314 is a newly described, surface exposed protein that contributes to the virulence properties of E. faecalis.
Authors: I T Paulsen; L Banerjei; G S A Myers; K E Nelson; R Seshadri; T D Read; D E Fouts; J A Eisen; S R Gill; J F Heidelberg; H Tettelin; R J Dodson; L Umayam; L Brinkac; M Beanan; S Daugherty; R T DeBoy; S Durkin; J Kolonay; R Madupu; W Nelson; J Vamathevan; B Tran; J Upton; T Hansen; J Shetty; H Khouri; T Utterback; D Radune; K A Ketchum; B A Dougherty; C M Fraser Journal: Science Date: 2003-03-28 Impact factor: 47.728
Authors: L Baldassarri; R Creti; S Recchia; M Pataracchia; G Alfarone; G Orefici; D Campoccia; L Montanaro; C R Arciola Journal: Int J Artif Organs Date: 2006-04 Impact factor: 1.595
Authors: R Creti; E Ceccarelli; M Bocchetta; A M Sanangelantoni; O Tiboni; P Palm; P Cammarano Journal: Proc Natl Acad Sci U S A Date: 1994-04-12 Impact factor: 11.205
Authors: A Toledo-Arana; J Valle; C Solano; M J Arrizubieta; C Cucarella; M Lamata; B Amorena; J Leiva; J R Penadés; I Lasa Journal: Appl Environ Microbiol Date: 2001-10 Impact factor: 4.792
Authors: D A Garsin; C D Sifri; E Mylonakis; X Qin; K V Singh; B E Murray; S B Calderwood; F M Ausubel Journal: Proc Natl Acad Sci U S A Date: 2001-09-04 Impact factor: 11.205
Authors: Shin Yong Park; Yong Pyo Shin; Chong Han Kim; Ho Jin Park; Yeon Sun Seong; Byung Sam Kim; Sook Jae Seo; In Hee Lee Journal: J Immunol Date: 2008-11-01 Impact factor: 5.422
Authors: Sabina Leanti La Rosa; Lars-Gustav Snipen; Barbara E Murray; Rob J L Willems; Michael S Gilmore; Dzung B Diep; Ingolf F Nes; Dag Anders Brede Journal: Infect Immun Date: 2015-03-16 Impact factor: 3.441